OSX2:F:F-Ossiam Lux - Ossiam US Minimum Variance NR (EUR)

ETF | Others |

Last Closing

USD 284.35

Change

+0.15 (+0.05)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-20 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

N/A

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

+0.06 (+0.11%)

USD 108.20B
SXR8:F iShares Core S&P 500 UCITS ETF..

N/A

USD 93.32B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

+0.01 (+0.02%)

USD 86.92B
SXRZ:F iShares VII PLC - iShares Nikk..

+0.65 (+0.27%)

USD 53.24B
VUSA:F Vanguard Funds Public Limited ..

+0.97 (+1.01%)

USD 51.63B
VUAA:F Vanguard S&P 500 UCITS Acc

-0.39 (-0.40%)

USD 51.63B
XDNY:F Xtrackers MSCI Japan ESG Scree..

N/A

USD 51.19B
XJSE:F Xtrackers II - Japan Governmen..

N/A

USD 41.09B
0ZC:F Zscaler Inc

+0.14 (+0.09%)

USD 37.92B

ETFs Containing OSX2:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 14.27% 76% C+ 70% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 14.27% 73% C 62% D
Trailing 12 Months  
Capital Gain 14.63% 62% D 64% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 14.63% 58% F 56% F
Trailing 5 Years  
Capital Gain 36.35% 61% D- 65% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 36.35% 61% D- 51% F
Average Annual (5 Year Horizon)  
Capital Gain 6.98% 63% D 63% D
Dividend Return 6.98% 61% D- 56% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 9.89% 67% D+ 88% B+
Risk Adjusted Return 70.56% 81% B- 85% B
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike